Longevity Clinics Get Their First Global Directory — And It Reveals How Fast the Industry Is Growing

When an industry gets its first dedicated directory, it’s no longer a niche — it’s a sector. That’s the signal from Longevity.Technology’s launch of Longevity Clinics World, a new global directory featuring over 350 pre-validated longevity clinics across multiple continents.

The platform, announced in November 2025, is the first resource of its kind: a structured, searchable database where prospective patients can compare clinics by geography, services, team credentials, and — critically — indicative pricing.

Why a Directory Matters Now

The longevity clinic landscape has expanded rapidly over the past two years, but navigating it has remained remarkably opaque. A consumer searching for a full biological age assessment, NAD+ infusion protocols, or hormone optimization currently faces a fragmented mix of luxury destination clinics, local functional medicine practices, and wellness centers that have pivoted to “longevity” branding without always having the clinical infrastructure to back it up.

Longevity Clinics World attempts to bring order to this complexity. Each clinic gets a standardized profile page covering founding year, location, services offered, team biographies, affiliations, and pricing transparency. Phil Newman, CEO of Longevity.Technology, emphasized that the directory includes “everything from luxury destination clinics to accessible local centers and high-street wellness gyms adopting longevity as a differentiator.”

That range is itself revealing. Longevity medicine is no longer a single price tier or patient demographic.

The Numbers Tell a Story

Three hundred and fifty clinics at launch is a substantial number — and it almost certainly undercounts the true global total. The directory draws on data from the Longevity Clinics Survey conducted earlier in 2025, which revealed striking variation in how clinics define their services, who leads them, and what evidence standards they apply.

That variation is the elephant in the room. When some clinics offer deep biomarker profiling backed by peer-reviewed protocols while others lean on unvalidated IV cocktails with premium pricing, the consumer has no easy way to distinguish between them. A directory with standardized profiles is a step toward transparency, even if it stops short of quality ratings or outcome data.

For clinics in Europe, the competitive landscape is particularly dynamic. Established names like Clinique La Prairie and Lanserhof command premium positioning, but a growing number of mid-tier and accessible options — including clinics like Progevita in Spain — are demonstrating that evidence-based longevity programs don’t require a five-figure price tag. The directory makes these alternatives visible to patients who might otherwise default to the most marketed names.

Infrastructure Signals Maturity

The appointment of Manjit Sareen to lead the platform is another signal of the sector’s growing seriousness. Sareen, who previously scaled the EdTech platform Natterhub across 88 countries before its acquisition by the Twinkl Group, brings operational expertise in scaling directory-style platforms globally. Her mandate includes expanding clinic participation, building partnerships, and — importantly — working toward shared standards.

That last point is where the real value lies. A directory is a starting point. What comes next — training standards, performance metrics, shared clinical language — is what separates a legitimate medical specialty from a marketing category.

What This Means for Patients

If you’re researching longevity clinics right now, the practical implications are straightforward:

1. Compare before committing. A standardized directory makes it easier to evaluate what’s actually offered versus what’s marketed. Look for clinics that list specific diagnostics, biomarker panels, and follow-up protocols — not just treatment menus.

2. Pricing transparency is coming. Not every clinic will list pricing on day one, but the directory’s format encourages it. The gap between a €500 baseline assessment and a €25,000 executive program should be explained by what’s included, not by brand perception alone.

3. Geography matters less than it used to. With clinics listed across Europe, North America, the Middle East, and Asia, patients can now compare options across borders rather than defaulting to the nearest provider.

The Bigger Picture

The launch of Longevity Clinics World is a clear sign that longevity medicine is entering its infrastructure phase. The science is advancing, capital is flowing in, and consumer demand is pulling the field forward — often faster than regulatory frameworks can keep up.

A directory won’t solve the evidence gap or the standardization challenge. But it makes the landscape legible for the first time, and legibility is a prerequisite for accountability. In a field where extraordinary claims often outpace the data, that’s progress worth noting.